(19)

(11)

EP 1 259 276 A2

(12)

(88) Date of publication A3: 28.03.2002 (43) Date of publication: 27.11.2002 Bulletin 2002/48 (21) Application number: 01917037.2 (22) Date of filing: 28.02.2001

(51) International Patent Classification (IPC)7: A61M 15/00, B65D 83/14 (86) International application number: PCT/EP0102/212 (87) International publication number: WO 0106/4273 (07.09.2001 Gazette 2001/36)

(84) Designated Contracting States: AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR Designated Extension States: AL LT LV MK RO SI (30) Priority: 01.03.2000 GB 0004761 28.07.2000 GB 0018624 28.07.2000 GB 0018653 (71) Applicant: GLAXO GROUP LIMITED Greenford, Middlesex UB6 ONN (GB)	(72) Inventor: HAILEY, Mark Andrew,c/o Glaxo Wellcome plc Hertfordshire SG12 0DJ (GB) (74) Representative: Giddings, Peter John, Dr.  GlaxoSmithKlineCorporate Intellectual Property (CN9.25.1)980 Great West Road Brentford, Middlesex TW8 9GS Brentford, Middlesex TW8 9GS (GB)